High-density lipoprotein-related inflammation indices and reproductive lifespan in women: insights from NHANES 2007–2018 Authors: Jie Liao, Tingting Liu, Biao Huang, Xin Li, Aijie Xie, Hengxi Chen Published: 2025 ABSTRACT BackgroundReproductive lifespan (RLS), defined as the interval between menarche and menopause, reflects the trajectory of ovarian aging. While high-density lipoprotein cholesterol (HDL-C) plays a key role in reproductive health, the association between HDL-related inflammatory indices and RLS remains unclear. This study investigated the relationship between HDL-related inflammatory indices—including lymphocyte-to-HDL-C ratio (LHR), monocyte-to-HDL-C ratio (MHR), neutrophil-to-HDL-C ratio (NHR), and platelet-to-HDL-C ratio (PHR)—and RLS among women.MethodsWe analyzed 4,841 naturally postmenopausal women from the 2007–2018 NHANES dataset. Multivariable linear regression models, weighted for complex survey design, were used to assess associations between log2-transformed HDL-related inflammatory indices and RLS. Restricted cubic spline models examined nonlinear associations. Subgroup and interaction analyses were performed.ResultsAll four HDL-related indices were significantly and inversely associated with RLS. In fully adjusted models, participants in the highest tertile of LHR, MHR, NHR, and PHR had RLS shortened by 1.45, 2.24, 2.14, and 1.11 years, respectively, compared with the lowest tertile. RCS analyses showed linear negative trends for LHR, MHR, NHR and PHR. Subgroup analyses revealed that diabetes modified the LHR–RLS relationship, while both diabetes and hypertension modified the PHR–RLS association. Stronger associations were consistently observed in women without metabolic comorbidities.ConclusionElevated HDL-related inflammatory indices were found to be associated with reduced RLS in this cross-sectional analysis, suggesting a possible link between chronic inflammation, lipid dysregulation, and ovarian aging. While these indices may have potential as accessible biomarkers for reproductive aging, the observational nature of this study limits causal inference. Further prospective investigations are warranted to confirm these associations and to clarify their clinical relevance. Introduction High-density lipoprotein cholesterol (HDL-C) is a vital component of blood lipids and plays a central role in lipid metabolism and cardiovascular protection [1]. High-density lipoprotein (HDL), commonly referred to as “good cholesterol,” mediates reverse cholesterol transport by removing excess cholesterol from peripheral tissues and delivering it to the liver. HDL-C specifically refers to the cholesterol content within HDL particles [2]. In recent years, several HDL-C–based inflammatory indices—such as the lymphocyte-to-HDL-C ratio (LHR), neutrophil-to-HDL-C ratio (NHR), monocyte-to-HDL-C ratio (MHR), and platelet-to-HDL-C ratio (PHR)—have gained increasing attention. These indices, derived from routine hematological and lipid parameters, simultaneously reflect systemic inflammation and lipid metabolic status, and have shown utility in predicting disease risks across various clinical conditions [3–6]. Reproductive lifespan (RLS), defined as the duration between menarche and menopause, reflects the active functional period of the ovaries, encompassing both maturation and gradual decline of ovarian function [7]. A growing body of evidence indicates that shorter RLS is associated with adverse health outcomes, including cardiovascular disease [8], hypertension [9], reduced pulmonary function [10], and chronic kidney disease [11]. Compared to evaluating the age at menarche or menopause separately, RLS provides a more integrated and informative measure of female reproductive aging and related health risks. The underlying biological mechanism is the progressive loss of oocytes in both number and quality, which ultimately leads to the cessation of ovarian function [12, 13]. Although the mechanisms of ovarian aging remain incompletely understood, increasing evidence suggests that disruptions in lipid metabolism—particularly involving HDL-C—may play a key role in accelerating ovarian senescence [14]. RLS reflects the duration of ovarian function from menarche to menopause, is crucial for women’s health, as a shorter RLS is associated with increased risks of cardiovascular disease and other health complications [15, 16]. HDL-C, known for its role in lipid metabolism, has been linked to ovarian aging through its inflammatory markers, and understanding these relationships could provide insights into early reproductive decline. HDL-C in follicular fluid has multiple protective functions, including promoting cholesterol efflux, reducing oxidative stress, and exerting anti-inflammatory effects, all of which are critical for maintaining oocyte quality [17–19]. Reduced HDL-C levels have been associated with impaired oocyte maturation and developmental potential. HDL-C enters follicular fluid via passive diffusion from the serum and contributes to creating a favorable ovarian microenvironment [20]. Its antioxidant properties help reduce lipid peroxidation, thereby mitigating oxidative injury to oocytes [21, 22]. Moreover, HDL-C levels are closely linked to insulin resistance, which can alter sex hormone balance, impair folliculogenesis, and negatively affect reproductive health. Given HDL-C’s essential role in preserving ovarian function, it is plausible that inflammatory indices based on HDL-C, such as LHR, MHR, NHR, and PHR, may serve as novel composite biomarkers reflecting both immune-inflammatory activity and reproductive aging. These indices may provide a more holistic assessment than isolated lipid or hematological markers. Although existing research has examined reproductive aging from various perspectives, no study to date has systematically investigated the relationship between HDL-related inflammatory indices and RLS. Therefore, the present study aimed to explore the associations between these composite inflammatory indices and RLS in a large, population-based dataset. By examining these indices as markers of systemic inflammation, the study seeks to identify potential links between inflammation, lipid metabolism, and ovarian aging. Through this analysis, we hope to contribute to the growing body of evidence on the biological mechanisms influencing reproductive aging and provide insight into the clinical utility of these indices for evaluating women’s reproductive health. Methods Study design and population This cross-sectional study utilized publicly available data from the National Health and Nutrition Examination Survey (NHANES) collected between 2007 and 2018 (P#2005-06). NHANES is a nationally representative survey of the U.S. non-institutionalized population, conducted by the National Center for Health Statistics (NCHS), integrating interviews, physical examinations, and laboratory testing. All participants provided written informed consent, and the survey protocol was approved by the NCHS Institutional Review Board. Women were eligible for inclusion if they reported natural menopause and had complete data on age at menarche and menopause. Exclusion criteria included: (1) history of hysterectomy or bilateral oophorectomy before menopause; (2) missing or implausible values for age at menarche (>18 years); and (3) missing data on HDL-related inflammatory indices. A total of 4,841 postmenopausal women were included in the final analysis. We applied the appropriate complex sampling weights for each year in the NHANES dataset to account for the stratified survey design, ensuring that our results accurately reflect the national population. Definition of reproductive lifespan RLS was calculated as the difference between self-reported age at menopause and age at menarche. For descriptive purposes, RLS was categorized into tertiles: <35 years (T1), 35–38 years (T2), and >38 years (T3). These tertile cutoffs were based on previous studies [23], which used these thresholds to indicate potential ovarian insufficiency (RLS < 35 years) and increased estrogen exposure (RLS >38 years) with associated reproductive system cancer risks. HDL-related inflammation indices Four inflammatory indices were calculated using the complete blood count and HDL-C measurements: Lymphocyte-to-HDL-C ratio (LHR) = Lymphocyte count/HDL-C; Monocyte-to-HDL-C ratio (MHR) = Monocyte count/HDL-C; Neutrophil-to-HDL-C ratio (NHR) = Neutrophil count/HDL-C; Platelet-to-HDL-C ratio (PHR) = Platelet count/HDL-C. Blood cell counts were measured using a Beckman Coulter automated hematology analyzer. HDL-C was measured enzymatically using the HDLC4 method. All indices were log2-transformed due to skewed distribution. The calculation of the HDL-related inflammatory indices, including LHR, MHR, NHR, and PHR, is based on methods validated in previous studies [24, 25]. Covariates Demographic and clinical covariates included age, race/ethnicity, education, marital status, poverty-to-income ratio (PIR), smoking status, alcohol consumption, body mass index (BMI), diabetes, hypertension, oral contraceptive use, and hormone therapy. These variables were selected based on biological plausibility and previous literature. Statistical analysis We pooled six 2-year NHANES cycles (2007–2008 through 2017–2018). According to the NCHS analytic guidelines, we created a 12-year examination weight by dividing the 2-year MEC weight by the number of combined cycles: WTMEC12YR = WTMEC2YR/6. All analyses accounted for the complex survey design, including strata (SDMVSTRA), primary sampling units (SDMVPSU), and the combined 12-year weights. Participants with zero or missing weights for a given analysis were further excluded. Continuous and categorical variables were compared across RLS tertiles using weighted t-tests and chi-square tests, respectively. Multivariable linear regression models were used to estimate the association between each HDL-related index and RLS. Three models were constructed: Model 1 adjusted for survey cycle indicators; Model 2 additionally adjusted for age, race, and education; Model 3 further adjusted for marital status, PIR, BMI, smoking status, diabetes, hypertension, contraceptive use, and use of female hormones. For participants with missing data, we conducted a full case analysis, excluding any observations with missing values for key variables such as HDL-related inflammatory indices, reproductive lifespan (RLS), and covariates. The extent of missing data was minimal, with less than 5% of the dataset having missing values. No imputation methods were used, as the proportion of missing data was small and did not significantly affect the analysis. Restricted cubic spline (RCS) models were used to examine the potential nonlinear associations between HDL-related inflammatory indices and RLS, adjusting for all covariates. Both the overall association and the nonlinearity were formally tested. Subgroup analyses and interaction tests were conducted by stratifying participants according to diabetes status, hypertension, BMI, oral contraceptive use, and hormone therapy. All analyses were performed using R (version 4.1.3) and EmpowerStats (version 2.0), with a two-sided P-value < 0.05 considered statistically significant. Results In this study, a total of 30,213 female participants from the 2007–2018 NHANES cycles were initially considered. Of these, 22,360 were excluded due to insufficient data for calculating reproductive lifespan, leaving 7,853 participants. Subsequently, 2,708 women who had undergone hysterectomy or bilateral oophorectomy before reaching menopausal age were excluded, resulting in 5,145 participants. An additional 20 participants with age at menarche greater than 18 years were further excluded, yielding 5,125 participants. Finally, 284 individuals lacking sufficient data to calculate LHR, MHR, NHR, and PHR were excluded. Thus, 4,841 participants were included in the final analysis (Fig. 1). The mean RLSwas 34.02 ± 8.34 years. The mean values of HDL-related inflammatory indices were as follows: LHR 0.04 ± 0.03, MHR 0.01 ± 0.01, NHR 0.08 ± 0.04, and PHR 4.63 ± 1.93. Baseline characteristics of the participants across RLS tertiles are summarized in Table 1. Women in the lowest RLS tertile (< 35 years) tended to be younger, with lower BMI and poverty-to-income ratio (PIR), less likely to be married, and more likely to have lower education levels and smoking history. In contrast, women in the highest RLS tertile (> 38 years) were older, more often non-Hispanic white, had higher PIR and BMI, were more likely to be married or cohabiting, and reported higher usage rates of oral contraceptives and female hormone therapy, as well as a higher prevalence of hypertension. Fig. 1The selection process for this study The selection process for this study Table 1Characteristics of participants enrolled in NHANES cross-sectional studyCharacteristicsRLSP value<35 years35–38 years>38 yearsPoverty-income ratio (PIR) (mean ± SE)2.81 ± 1.623.06 ± 1.573.37 ± 1.53< 0.001BMI, kg/m2 (mean ± SE)29.14 ± 7.2829.27 ± 7.1729.87 ± 7.340.009Race/ethnicity, (%)< 0.001 Mexican American7.295.913.67 Other Hispanic5.844.484.10 Non-Hispanic White69.4975.8579.03 Non-Hispanic Black10.907.856.97 Other races6.475.926.23Educational attainments (%)< 0.001 under high school18.9314.6312.81 High school26.6525.2322.56 higher than high school54.4260.1564.63Marital status, (%)< 0.001 Married/Living with partner57.0058.6660.95 Widowed/Divorced/Separated33.0735.1934.47 Never married9.936.154.58Hypertension, n (%)40.7046.9752.46< 0.001Diabetes mellitus, n (%)12.2914.5414.490.088Ever used Female Hormones, n (%)26.6428.4731.780.003Ever used OC67.3572.0273.30< 0.001Smoked at least 100 cigarettes in life45.9739.1336.23< 0.001 LHR0.042 ± 0.0210.037 ± 0.0200.037 ± 0.027< 0.001 MHR0.010 ± 0.0050.010 ± 0.0050.009 ± 0.005< 0.001 NHR0.081 ± 0.0450.073 ± 0.0400.071 ± 0.041< 0.001 PHR4.714 ± 1.9224.454 ± 2.0314.274 ± 1.732< 0.001Mean ± SD for continuous variables: the P value was calculated by the weighted linear regression model; (%) for categorical variables: the P value was calculated by the weighted chi-square test.Abbreviation: PIR the ratio of income to poverty, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LHR lymphocyte count/high-density lipoprotein cholesterol, MHR monocyte count/high-density lipoprotein cholesterol, NHR neutrophil count/high-density lipoprotein cholesterol, OC oral contraceptives, PHR platelet count/high-density lipoprotein cholesterol, RLS reproductive lifespan Table 1Characteristics of participants enrolled in NHANES cross-sectional studyCharacteristicsRLSP value<35 years35–38 years>38 yearsPoverty-income ratio (PIR) (mean ± SE)2.81 ± 1.623.06 ± 1.573.37 ± 1.53< 0.001BMI, kg/m2 (mean ± SE)29.14 ± 7.2829.27 ± 7.1729.87 ± 7.340.009Race/ethnicity, (%)< 0.001 Mexican American7.295.913.67 Other Hispanic5.844.484.10 Non-Hispanic White69.4975.8579.03 Non-Hispanic Black10.907.856.97 Other races6.475.926.23Educational attainments (%)< 0.001 under high school18.9314.6312.81 High school26.6525.2322.56 higher than high school54.4260.1564.63Marital status, (%)< 0.001 Married/Living with partner57.0058.6660.95 Widowed/Divorced/Separated33.0735.1934.47 Never married9.936.154.58Hypertension, n (%)40.7046.9752.46< 0.001Diabetes mellitus, n (%)12.2914.5414.490.088Ever used Female Hormones, n (%)26.6428.4731.780.003Ever used OC67.3572.0273.30< 0.001Smoked at least 100 cigarettes in life45.9739.1336.23< 0.001 LHR0.042 ± 0.0210.037 ± 0.0200.037 ± 0.027< 0.001 MHR0.010 ± 0.0050.010 ± 0.0050.009 ± 0.005< 0.001 NHR0.081 ± 0.0450.073 ± 0.0400.071 ± 0.041< 0.001 PHR4.714 ± 1.9224.454 ± 2.0314.274 ± 1.732< 0.001Mean ± SD for continuous variables: the P value was calculated by the weighted linear regression model; (%) for categorical variables: the P value was calculated by the weighted chi-square test.Abbreviation: PIR the ratio of income to poverty, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LHR lymphocyte count/high-density lipoprotein cholesterol, MHR monocyte count/high-density lipoprotein cholesterol, NHR neutrophil count/high-density lipoprotein cholesterol, OC oral contraceptives, PHR platelet count/high-density lipoprotein cholesterol, RLS reproductive lifespan Characteristics of participants enrolled in NHANES cross-sectional study Mean ± SD for continuous variables: the P value was calculated by the weighted linear regression model; (%) for categorical variables: the P value was calculated by the weighted chi-square test. Abbreviation: PIR the ratio of income to poverty, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LHR lymphocyte count/high-density lipoprotein cholesterol, MHR monocyte count/high-density lipoprotein cholesterol, NHR neutrophil count/high-density lipoprotein cholesterol, OC oral contraceptives, PHR platelet count/high-density lipoprotein cholesterol, RLS reproductive lifespan Multivariate linear regression analyses demonstrated significant inverse associations between HDL-related inflammatory indices and RLS. In the fully adjusted model (Model 3), increases in log2-transformed LHR, MHR, NHR, and PHR were associated with shorter RLS (β = −0.65, −1.44, −1.29, and − 0.73, respectively; all p < 0.001). When categorized into tertiles, women in the highest tertile of each index had significantly shorter RLS than those in the lowest tertile: LHR by 1.45 years, MHR by 2.24 years, NHR by 2.14 years, and PHR by 1.11 years (Table 2). Table 2Weighted multivariable regression analysis of association between HDL- related inflammation index and reproductive lifespanExposureReproductive time life (years)Model 1Model 2Model 3Beta (95% CI)P-valueBeta (95% CI)P-valueBeta (95% CI)P-valueLog 2 (NHR)−1.63 (−1.94, −1.31)< 0.001−1.02 (−1.29, −0.75)< 0.001−1.29 (−1.57, −1.00)< 0.001NHR categorical T1000 T2−1.27 (−1.85, −0.69)< 0.001−1.18 (−1.67, −0.70)< 0.001−1.32 (−1.80, −0.84)< 0.001 T3−2.95 (−3.54, −2.37)< 0.001−1.77 (−2.27, −1.27)< 0.001−2.14 (−2.67, −1.62)< 0.001P for trend−2.04 (−2.45, −1.64)< 0.001−1.24 (−1.59, −0.89)< 0.001−1.50 (−1.86, −1.13)< 0.001Log 2 (PHR)−2.10 (−2.52, −1.68)< 0.001−0.55 (−0.91, −0.19)0.003−0.73 (−1.10, −0.35)< 0.001PHR categorical T1000 T2−0.97 (−1.55, −0.39)0.001−0.41 (−0.90, 0.08)0.098−0.70 (−1.18, −0.23)0.004 T3−2.94 (−3.52, −2.35)< 0.001−0.87 (−1.38, −0.37)< 0.001−1.11 (−1.62, −0.59)< 0.001P for trend−2.68 (−3.22, −2.14)< 0.001−0.80 (−1.27, −0.34)< 0.001−1.03 (−1.50, −0.56)< 0.001Abbreviation: PIR the ratio of income to poverty, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LHR lymphocyte count/high-density lipoprotein cholesterol, MHR monocyte count/high-density lipoprotein cholesterol, NHR neutrophil count/high-density lipoprotein cholesterol, OC oral contraceptives, PHR platelet count/high-density lipoprotein cholesterol, RLS reproductive lifespanModel 1: survey cycle indicators were adjustedModel 2: survey cycle indicators, Age, race, education level were adjustedModel 3: survey cycle indicators, Age, race, education level, Marital status, PIR, BMI, smoking status, Hypertension, Diabetes mellitus, OC use, Female Hormones use Table 2Weighted multivariable regression analysis of association between HDL- related inflammation index and reproductive lifespanExposureReproductive time life (years)Model 1Model 2Model 3Beta (95% CI)P-valueBeta (95% CI)P-valueBeta (95% CI)P-valueLog 2 (NHR)−1.63 (−1.94, −1.31)< 0.001−1.02 (−1.29, −0.75)< 0.001−1.29 (−1.57, −1.00)< 0.001NHR categorical T1000 T2−1.27 (−1.85, −0.69)< 0.001−1.18 (−1.67, −0.70)< 0.001−1.32 (−1.80, −0.84)< 0.001 T3−2.95 (−3.54, −2.37)< 0.001−1.77 (−2.27, −1.27)< 0.001−2.14 (−2.67, −1.62)< 0.001P for trend−2.04 (−2.45, −1.64)< 0.001−1.24 (−1.59, −0.89)< 0.001−1.50 (−1.86, −1.13)< 0.001Log 2 (PHR)−2.10 (−2.52, −1.68)< 0.001−0.55 (−0.91, −0.19)0.003−0.73 (−1.10, −0.35)< 0.001PHR categorical T1000 T2−0.97 (−1.55, −0.39)0.001−0.41 (−0.90, 0.08)0.098−0.70 (−1.18, −0.23)0.004 T3−2.94 (−3.52, −2.35)< 0.001−0.87 (−1.38, −0.37)< 0.001−1.11 (−1.62, −0.59)< 0.001P for trend−2.68 (−3.22, −2.14)< 0.001−0.80 (−1.27, −0.34)< 0.001−1.03 (−1.50, −0.56)< 0.001Abbreviation: PIR the ratio of income to poverty, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LHR lymphocyte count/high-density lipoprotein cholesterol, MHR monocyte count/high-density lipoprotein cholesterol, NHR neutrophil count/high-density lipoprotein cholesterol, OC oral contraceptives, PHR platelet count/high-density lipoprotein cholesterol, RLS reproductive lifespanModel 1: survey cycle indicators were adjustedModel 2: survey cycle indicators, Age, race, education level were adjustedModel 3: survey cycle indicators, Age, race, education level, Marital status, PIR, BMI, smoking status, Hypertension, Diabetes mellitus, OC use, Female Hormones use Weighted multivariable regression analysis of association between HDL- related inflammation index and reproductive lifespan Abbreviation: PIR the ratio of income to poverty, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LHR lymphocyte count/high-density lipoprotein cholesterol, MHR monocyte count/high-density lipoprotein cholesterol, NHR neutrophil count/high-density lipoprotein cholesterol, OC oral contraceptives, PHR platelet count/high-density lipoprotein cholesterol, RLS reproductive lifespan Model 1: survey cycle indicators were adjusted Model 2: survey cycle indicators, Age, race, education level were adjusted Model 3: survey cycle indicators, Age, race, education level, Marital status, PIR, BMI, smoking status, Hypertension, Diabetes mellitus, OC use, Female Hormones use Restricted cubic spline (RCS) models were used to visualize the adjusted nonlinear associations between HDL-related inflammatory indices and RLS, accounting for all relevant covariates. All four HDL-related indices showed significant inverse associations with reproductive lifespan (all P for overall < 0.001), and these associations appeared linear (all P for non-linearity > 0.05) (Fig. 2A–D). These findings suggest and underscore the need for further mechanistic investigation. Fig. 2Nonlinear associations between hdl-related inflammatory indices and RLS based on restricted cubic spline models. Restricted cubic spline (RCS) analyses illustrating the associations between log₂-transformed HDL-related inflammation indices and RLS, adjusted for age, race/ethnicity, education level, marital status, poverty-to-income ratio (PIR), body mass index (BMI), smoking status, hypertension, diabetes mellitus, oral contraceptive use, and female hormone use. The four panels represent: (A) log₂(LHR) vs. RLS, (B) log₂(MHR) vs. RLS, (C) log₂(NHR) vs. RLS, and (D) log₂(PHR) vs. RLS. Blue dots indicate observed values, and red lines represent the fitted RCS curves. Abbreviations: LHR, lymphocyte-to-HDL-C ratio; MHR, monocyte-to-HDL-C ratio; NHR, neutrophil-to-HDL-C ratio; PHR, platelet-to-HDL-C ratio; HDL-C, high-density lipoprotein cholesterol; PIR, poverty-to-income ratio; BMI, body mass index; OC, oral contraceptive; RLS, RLS Nonlinear associations between hdl-related inflammatory indices and RLS based on restricted cubic spline models. Restricted cubic spline (RCS) analyses illustrating the associations between log₂-transformed HDL-related inflammation indices and RLS, adjusted for age, race/ethnicity, education level, marital status, poverty-to-income ratio (PIR), body mass index (BMI), smoking status, hypertension, diabetes mellitus, oral contraceptive use, and female hormone use. The four panels represent: (A) log₂(LHR) vs. RLS, (B) log₂(MHR) vs. RLS, (C) log₂(NHR) vs. RLS, and (D) log₂(PHR) vs. RLS. Blue dots indicate observed values, and red lines represent the fitted RCS curves. Abbreviations: LHR, lymphocyte-to-HDL-C ratio; MHR, monocyte-to-HDL-C ratio; NHR, neutrophil-to-HDL-C ratio; PHR, platelet-to-HDL-C ratio; HDL-C, high-density lipoprotein cholesterol; PIR, poverty-to-income ratio; BMI, body mass index; OC, oral contraceptive; RLS, RLS Subgroup analyses were conducted to assess whether the associations between HDL-related inflammatory indices and RLSwere modified by BMI, hypertension, diabetes mellitus, oral contraceptive (OC) use, and female hormone use. For log₂(LHR), a significant inverse association with RLS was observed across all BMI categories and among participants without diabetes, with a significant interaction detected only for diabetes status (P for interaction = 0.0452), suggesting the association was present in non-diabetic individuals but not in those with diabetes (Fig. 3A). For log₂(MHR), the inverse association with RLS was more pronounced in participants without hypertension (β = −1.8; 95% CI: −2.2, −1.4), with a significant interaction by hypertension status (P for interaction = 0.0047), indicating that hypertensive status modified the effect (Fig. 3B). Similarly, the association between log₂(NHR) and RLS showed a stronger negative effect in participants without hypertension (β = −1.5; 95% CI: −1.9, −1.2), with significant interaction (P for interaction = 0.0036) (Fig. 3C). For log₂(PHR), negative associations were observed mainly in participants without diabetes or hypertension, and both conditions showed significant interaction effects (P for interaction = 0.012 for diabetes; P = 0.0471 for hypertension), indicating that the predictive value of PHR for RLS may be diminished in individuals with metabolic comorbidities (Fig. 3D). No significant interactions were found with BMI, OC use, or female hormone use in any of the models. Fig. 3Subgroup analyses of the associations between hdl-related inflammatory indices and RLS. Forest plots depict the stratified associations between log₂-transformed HDL-related inflammatory indices and RLSacross subgroups defined by BMI, hypertension, diabetes mellitus, oral contraceptive use, and female hormone use. Interaction p-values assess the heterogeneity of associations within each subgroup. A log₂(LHR) and RLS; (B) log₂(MHR) and RLS; (C) log₂(NHR) and RLS; (D) log₂(PHR) and RLS Subgroup analyses of the associations between hdl-related inflammatory indices and RLS. Forest plots depict the stratified associations between log₂-transformed HDL-related inflammatory indices and RLSacross subgroups defined by BMI, hypertension, diabetes mellitus, oral contraceptive use, and female hormone use. Interaction p-values assess the heterogeneity of associations within each subgroup. A log₂(LHR) and RLS; (B) log₂(MHR) and RLS; (C) log₂(NHR) and RLS; (D) log₂(PHR) and RLS Discussion In this study, we evaluated the associations between HDL-related inflammation indices—LHR, MHR, NHR, and PHR—and RLSusing data from the NHANES 2007–2018 cycles. Our findings revealed that higher levels of these indices were significantly and independently associated with shorter RLS. Subgroup analyses further demonstrated that the association between LHR and RLS varied according to diabetes status, while the association between PHR and RLS was modified by both diabetes and hypertension status. The ovarian follicle is the fundamental functional unit governing RLS. Women are born with approximately 1–2 million primordial follicles, which undergo continuous atresia over time. After the age of 31, the depletion of the ovarian reserve accelerates, accompanied by a progressive decline in oocyte quality, ultimately leading to decreased fertility. Once the follicle pool drops below a critical threshold—approximately 1,000—natural menopause typically occurs around age 50, marking the cessation of reproductive capacity [26]. Numerous epidemiological studies have suggested that inflammation and lipid metabolism are intricately linked to ovarian aging and function [27]. The HDL-related inflammation indices evaluated in this study integrate markers of systemic inflammation and lipid metabolism, offering a more comprehensive view of the pathophysiological processes underlying ovarian aging. Elevation in these indices may reflect chronic low-grade inflammation and metabolic imbalance, both of which are known contributors to reproductive aging. LHR, MHR, NHR, and PHR are derived from combining HDL-C with leukocyte and platelet counts—namely, lymphocytes, monocytes, neutrophils, and platelets. Each of these components is involved in immune regulation and oxidative stress pathways, which are increasingly recognized as critical in ovarian aging [18, 28]. Lymphocytes play a central role in adaptive immunity [29], and aberrant T-lymphocyte regulation, such as via Peli1 expression, can lead to autoimmune-mediated ovarian insufficiency [30]. Proteomic analyses of aging ovaries have identified increased levels of inflammatory and immune-related proteins, suggesting enhanced lymphocyte-mediated immune responses during ovarian senescence [31]. Monocytes, typically elevated during systemic inflammation, are involved in both the initiation and resolution of inflammatory processes [32], and excessive monocyte chemoattractant protein-1 (MCP-1) has been linked to diminished ovarian reserve [33]. Ovarian monocyte infiltration also increases with age [34]. Neutrophils, the most abundant leukocytes, are key effectors in innate immunity and contribute to inflammation through the generation of reactive oxygen species (ROS) [35]. Given that ROS production in the corpus luteum is largely neutrophil-driven, oxidative stress from neutrophils may promote follicular decline [36]. Platelets serve as immune sentinels and interact with leukocytes to amplify inflammation. Their activation in the ovarian microenvironment—especially in pathological states such as cancer—has been shown to promote angiogenesis, cytokine release, and disease progression. Collectively, increased lymphocyte, monocyte, neutrophil, and platelet activity promotes chronic ovarian inflammation and oxidative stress, key hallmarks of reproductive aging [27], and ultimately contributes to decreased oocyte quality and shortened RLS [26]. HDL-C, in contrast, exerts protective effects by reducing oxidase activity, limiting oxidative damage, and modulating inflammatory pathways in vascular and reproductive tissues [37]. It carries anti-inflammatory and complement-regulating proteins that help protect against infection and inflammation [38]. Therefore, an elevated HDL-related inflammation index likely indicates an imbalance characterized by increased proinflammatory cell counts and decreased HDL-C levels, reflecting enhanced oxidative and inflammatory burden in the ovarian microenvironment. This mechanism aligns with our findings that higher HDL-related indices are associated with shorter RLS. Several studies have examined the relationship between HDL-C and reproductive lifespan, with mixed results. For example, a significant association between HDL-C levels and ovarian aging were found, whereas other studies, reported no clear link between HDL-C and reproductive lifespan [39, 40]. The discrepancies in findings may be attributed to differences in study design, population characteristics, and the specific inflammatory markers used to assess lipid metabolism. These variations underscore the complexity of the relationship between HDL-C and ovarian aging, warranting further investigation into the underlying mechanisms. Subgroup analyses suggest that the impact of these indices may differ by comorbid metabolic conditions. For instance, the inverse association between LHR and RLS was only significant among non-diabetic individuals, suggesting that chronic hyperglycemia, autoimmune disruption, or insulin resistance in diabetes may overshadow the contribution of inflammatory markers [41]. Similarly, the association between PHR and RLS appeared more prominent in women without diabetes or hypertension. Hypertension is often accompanied by oxidative stress and vascular endothelial dysfunction, which may directly impair ovarian blood flow and function, thereby diminishing the additive predictive value of HDL-related inflammatory indices in these populations. Moreover, our findings on HDL-related inflammatory indices are consistent with several genetic insights into ovarian aging, as described by Ruth KS et al. and Jin C et al. [42, 43], where similar biological mechanisms related to inflammation and lipid metabolism were implicated in the regulation of ovarian reserve. Several limitations must be acknowledged. Given the cross-sectional design, causal inferences cannot be established. Additionally, key hormonal parameters such as serum estrogen, follicle-stimulating hormone, and luteinizing hormone were not available in the NHANES dataset and thus could not be controlled for. Other relevant reproductive indicators—such as menstrual cycle regularity, ovulatory status, and bone turnover markers—were also lacking [44]. Moreover, reliance on self-reported ages at menarche and menopause may introduce recall bias, although such data have been validated in prior population studies. Finally, while we observed a nonlinear association between PHR and RLS, the underlying biological rationale remains unclear and warrants further investigation. The mean RLS of 34.02 years observed in our study suggests a trend toward ovarian insufficiency and its potential impact on women’s health. This finding is consistent with increasing concerns about the declining ovarian reserve and its early onset in some women [45]. A shorter RLS could have far-reaching consequences, including reduced fertility potential, earlier onset of menopause, and possible long-term effects on cardiovascular and bone health. Furthermore, a shortened RLS may reflect broader environmental and lifestyle factors, such as poor nutrition, high stress levels, and environmental toxins, all of which contribute to ovarian dysfunction [46]. These observations underline the importance of early detection and interventions to preserve reproductive health and improve overall well-being in women. Nonetheless, HDL-related inflammation indices represent promising, low-cost composite biomarkers that integrate lipid and immune-inflammatory information. As they are easily derived from routine blood tests, these indices hold potential for widespread application in identifying women at risk of accelerated reproductive aging, especially in resource-limited settings. If longitudinal studies confirm their predictive value, timely interventions aimed at modulating inflammatory or metabolic status could potentially help extend RLS. Despite these strengths, several limitations of the present study should be acknowledged. Given the cross-sectional design of this study, we cannot establish a causal relationship between HDL-related inflammatory indices and RLS. The associations observed may reflect correlations rather than causal pathways. The stability of HDL-related inflammatory indices over time is not assumed in this study, and the results should be viewed in light of the known biological variability of these biomarkers. While we conducted subgroup analyses based on diabetes and hypertension status, we recognize the limitation that the cross-sectional nature of the data prevents us from definitively establishing the timing of these conditions in relation to menopause. Therefore, we cannot conclude with certainty whether diabetes or hypertension preceded menopause in our study participants. These associations should be interpreted with caution, and future longitudinal studies are needed to assess the temporal relationship between these conditions and RLS. Conclusion This study reveals an inverse association between HDL-related inflammation indices—LHR, MHR, NHR, and PHR—and RLS. These findings indicate that elevated systemic inflammation and disrupted lipid metabolism, as reflected by higher HDL-related indices, may be linked to accelerated ovarian aging and earlier reproductive senescence. The interactions observed with diabetes and hypertension further suggest that underlying metabolic disorders could influence these associations. While these indices are derived from routine laboratory tests and may hold potential as accessible markers for reproductive aging, their clinical utility requires further confirmation. Additional longitudinal and mechanistic studies are needed to validate these associations and to clarify whether targeting inflammation and lipid metabolism might contribute to preserving reproductive health and extending RLS.